Microbot Medical
MBOT
49 hedge funds and large institutions have $11.1M invested in Microbot Medical in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 8 closing their positions.
2,464% more call options, than puts
Call options by funds: $4.64M | Put options by funds: $181K
240% more capital invested
Capital invested by funds: $3.26M → $11.1M (+$7.8M)
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
14% more funds holding
Funds holding: 43 → 49 (+6)
5.85% more ownership
Funds ownership: 6.21% → 12.06% (+5.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.13M |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$1.46M |
| 3 |
Morgan Stanley
New York
|
+$327K |
| 4 |
BlackRock
New York
|
+$204K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$187K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$173K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$63K |
| 3 |
VF
Virtu Financial
New York
|
-$42K |
| 4 |
TFS
Thoroughbred Financial Services
Brentwood,
Tennessee
|
-$40K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$34.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TFS
51
Thoroughbred Financial Services
Brentwood,
Tennessee
| – | -$40K | -27,000 | Closed |
|
52
Jane Street
New York
| – | -$23.5K | -15,583 | Closed |
|
|
TSS
53
Two Sigma Securities
New York
| – | -$22.4K | -14,823 | Closed |
|
54
Squarepoint
New York
| – | -$22.1K | -14,616 | Closed |
|
|
AF
55
Atala Financial
Calabasas,
California
| – | -$3 | -2 | Closed |
|
|
MCM
56
MAI Capital Management
Independence,
Ohio
| – | -$2 | -1 | Closed |
|
MBOT Hedge Fund Activity: Q2 2025 in Review
49 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2025, worth a combined $11.1M — up 240% from $3.26M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MBOT positions and 8 closed out — a net gain of 6 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.13M. The largest seller was Susquehanna International Group, cutting an estimated $173K.
- 49 institutional investors held Microbot Medical (MBOT) as of Q2 2025, up from 43 in Q1 2025.
- Funds reported $11.1M of Microbot Medical stock for Q2 2025, up 240% quarter-over-quarter.
- 14 funds opened new Microbot Medical positions in Q2 2025 and 8 closed out, a net change of +6 holders.
- The largest Microbot Medical buyer in Q2 2025 was Vanguard Group, an estimated $3.13M added.
- The largest Microbot Medical seller in Q2 2025 was Susquehanna International Group, an estimated $173K sold.
Based on aggregated 13F filings for Q2 2025.